Skip to main content
Erschienen in: International Urogynecology Journal 10/2016

15.03.2016 | Original Article

Risk of venous thromboembolism in patients undergoing surgery for pelvic organ prolapse

verfasst von: Erik D. Hokenstad, Elizabeth B. Habermann, Amy E. Glasgow, John A. Occhino

Erschienen in: International Urogynecology Journal | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

We sought to determine the incidence of venous thromboembolism (VTE) in patients undergoing surgery for pelvic organ prolapse (POP) based on surgical approach.

Methods

The American College of Surgeons National Quality Improvement Program (NSQIP) database was used to select all surgeries performed for POP from 2005 to 2013. CPT-4 codes were grouped based on surgical approach: vaginal (VAG), laparoscopic sacrocolpopexy (LSC), or open abdominal sacrocolpopexy (ASC). Patient demographics, preoperative American Society of Anesthesiologists (ASA) classification system scores, and 30-day postoperative complications were obtained.

Results

Of the 26,103 women who underwent surgery for POP, 21,311 (81.7 %) underwent VAG, 3,346 (12.8 %) LSC, and 1,426 (5.5 %) ASC. VTE occurred in 36 patients (0.17 %) in the VAG group, 8 (0.24 %) in the LSC group, and 9 (0.63 %) in the ASC group. The ASC group had a significantly higher incidence of VTE compared with the VAG group (p < 0.01). Upon multivariate analysis, factors associated with a greater incidence of VTE included BMI greater than 30 kg/m2 (p = 0.048), ASA score of 3, 4, or 5 (p = 0.027), and length of stay above the 75th percentile (p < 0.01). The procedure group did not retain statistical significance in multivariate modeling.

Conclusions

Venous thromboembolism is rare following surgery for POP. Although differences in VTE rates between procedure groups failed to maintain statistical significance after multivariate analysis, we were able to identify risk factors associated with an increased VTE risk in surgery for POP. Women with obesity, an increased length of stay, or ASA score of 3 or higher are at an increased risk for developing VTE after undergoing surgery for POP.
Literatur
1.
Zurück zum Zitat Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA et al (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141 [2 Suppl]:e227S–e277SCrossRefPubMedPubMedCentral Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA et al (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141 [2 Suppl]:e227S–e277SCrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Horlander KT, Mannino DM, Leeper KV (2003) Pulmonary embolism mortality in the United States, 1979–1998: an analysis using multiple-cause mortality data. Arch Intern Med 163(14):1711–1717CrossRefPubMed Horlander KT, Mannino DM, Leeper KV (2003) Pulmonary embolism mortality in the United States, 1979–1998: an analysis using multiple-cause mortality data. Arch Intern Med 163(14):1711–1717CrossRefPubMed
3.
Zurück zum Zitat Wu JM, Matthews CA, Conover MM, Pate V, Jonsson FM (2014) Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol 123(6):1201–1206CrossRefPubMedPubMedCentral Wu JM, Matthews CA, Conover MM, Pate V, Jonsson FM (2014) Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol 123(6):1201–1206CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Solomon ER, Frick AC, Paraiso MF, Barber MD (2010) Risk of deep venous thrombosis and pulmonary embolism in urogynecologic surgical patients. Am J Obstet Gynecol 203(5):510.e1–510.e4CrossRef Solomon ER, Frick AC, Paraiso MF, Barber MD (2010) Risk of deep venous thrombosis and pulmonary embolism in urogynecologic surgical patients. Am J Obstet Gynecol 203(5):510.e1–510.e4CrossRef
5.
Zurück zum Zitat Mueller MG, Pilecki MA, Catanzarite T, Jain U, Kim JY, Kenton K, Mueller MG, Pilecki MA, Catanzarite T, Jain U, Kim JY, Kenton K (2014) Venous thromboembolism in reconstructive pelvic surgery. Am J Obstet Gynecol 211(5):552.e1–552.e6CrossRef Mueller MG, Pilecki MA, Catanzarite T, Jain U, Kim JY, Kenton K, Mueller MG, Pilecki MA, Catanzarite T, Jain U, Kim JY, Kenton K (2014) Venous thromboembolism in reconstructive pelvic surgery. Am J Obstet Gynecol 211(5):552.e1–552.e6CrossRef
6.
Zurück zum Zitat Barber EL, Neubauer NL, Gossett DR (2015) Risk of venous thromboembolism in abdominal versus minimally invasive hysterectomy for benign conditions. Am J Obstet Gynecol 212(5):609.e1–609.e7CrossRef Barber EL, Neubauer NL, Gossett DR (2015) Risk of venous thromboembolism in abdominal versus minimally invasive hysterectomy for benign conditions. Am J Obstet Gynecol 212(5):609.e1–609.e7CrossRef
7.
Zurück zum Zitat Dripps RD, Lamont A, Eckenhoff JE (1961) The role of anesthesia in surgical mortality. JAMA 178:261–266CrossRefPubMed Dripps RD, Lamont A, Eckenhoff JE (1961) The role of anesthesia in surgical mortality. JAMA 178:261–266CrossRefPubMed
8.
Zurück zum Zitat Cohoon KP, Leibson CL, Ransom JE, Ashrani AA, Park MS, Petterson TM et al (2015) Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. Surgery 157(3):423–431CrossRefPubMedPubMedCentral Cohoon KP, Leibson CL, Ransom JE, Ashrani AA, Park MS, Petterson TM et al (2015) Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. Surgery 157(3):423–431CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133 [6 Suppl]:381S–453SCrossRefPubMed Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133 [6 Suppl]:381S–453SCrossRefPubMed
Metadaten
Titel
Risk of venous thromboembolism in patients undergoing surgery for pelvic organ prolapse
verfasst von
Erik D. Hokenstad
Elizabeth B. Habermann
Amy E. Glasgow
John A. Occhino
Publikationsdatum
15.03.2016
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 10/2016
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-016-2990-z

Weitere Artikel der Ausgabe 10/2016

International Urogynecology Journal 10/2016 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.